[HTML][HTML] Overcoming barriers in HPV vaccination and screening programs

A Vorsters, M Arbyn, M Baay, X Bosch… - Papillomavirus …, 2017 - Elsevier
Abstract The Human Papillomavirus Prevention and Control Board brought together experts
to discuss optimizing HPV vaccination and screening programs. Board members reviewed …

Prophylactic human papillomavirus vaccination: from the origin to the current state

A Akhatova, A Azizan, K Atageldiyeva… - Vaccines, 2022 - mdpi.com
Immunization is the most successful method in preventing and controlling infectious
diseases, which has helped saving millions of lives worldwide. The discovery of the human …

Upgrading public health programs for human papillomavirus prevention and control is possible in low-and middle-income countries

M Steben, J Jeronimo, S Wittet, DS LaMontagne… - Vaccine, 2012 - Elsevier
Cancer is an important cause of premature death in low-and middle-income countries
(LMIC). Two preventive tools are available that have the potential together to sharply …

[HTML][HTML] Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)

LE Markowitz, EF Dunne, M Saraiya, HW Chesson… - MMWR Recomm …, 2014 - cdc.gov
This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

Human papillomavirus vaccines: successes and future challenges

S Perez, GD Zimet, O Tatar, NW Stupiansky, WA Fisher… - Drugs, 2018 - Springer
Over a decade has passed since the first human papillomavirus (HPV) vaccine was
introduced. These vaccines have received unequivocal backing from the scientific and …

[HTML][HTML] Barriers, facilitators, and potential strategies for increasing HPV vaccination: A statewide assessment to inform action

KB Cartmell, J Young-Pierce, S McGue, AJ Alberg… - Papillomavirus …, 2018 - Elsevier
Objective The objective was to investigate how state level strategies in South Carolina could
maximize HPV vaccine uptake. Design An environmental scan identified barriers, facilitators …

[PDF][PDF] Human papillomavirus and cervical cancer: burden of illness and basis for prevention

H Trottier, EL Franco - Am J Manag Care, 2006 - ptce.s3.amazonaws.com
Genital infection with human papillomaviruses (HPV) is one of the most common sexually
transmitted conditions. The central causal role in cervical carcinogenesis of the so-called …

[HTML][HTML] National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects

VD Tsu, DS LaMontagne, P Atuhebwe, PN Bloem… - Preventive …, 2021 - Elsevier
More than 90% of cervical cancer deaths occur in low-and middle-income countries (LMICs),
which have limited capacity to mount the comprehensive national screening and precancer …

A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US

EF Dunne, SD Datta, L E. Markowitz - Cancer, 2008 - Wiley Online Library
It has been estimated that genital human papillomavirus (HPV) is the most common sexually
transmitted infection in the US. Nononcogenic types, such as HPV type 6 (HPV‐6) and HPV …

Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies

JE Tota, M Chevarie-Davis, LA Richardson… - Preventive …, 2011 - Elsevier
Human papillomavirus (HPV) infection is a necessary, although not sufficient cause of
cervical cancer. Globally, HPV infection accounts for an estimated 530,000 cervical cancer …